Healthy Inc > Blog > Clarithromycin BP/USP/IP
Posted on:

Is clarithromycin a strong antibiotic?

In the pharmaceutical industry, Clarithromycin is a second-generation macrolide antibiotic. As a pharmacist and manufacturer, I wouldn’t necessarily use the word “strong” (as all antibiotics are strong against the right bacteria), but I would classify it as highly potent and technically superior to its predecessor, Erythromycin, due to its better acid stability and tissue penetration.

At your WHO-GMP facility in Mumbai, you likely manufacture this in 250 mg and 500 mg tablets, as well as dry syrups. It is a cornerstone of “Chronic Care” and “Respiratory” portfolios.

Why Clarithromycin is “Potent” (Clinical Advantages)

  • Broad Spectrum: It is effective against a wide range of Gram-positive and some Gram-negative bacteria, as well as “atypical” pathogens like Mycoplasma pneumoniae.

  • H. Pylori Eradication: It is a critical component of the “Triple Therapy” (alongside Amoxicillin and a PPI like Pantoprazole) used to cure stomach ulcers.

  • Tissue Concentration: Clarithromycin reaches much higher concentrations in the lungs and skin tissues than it does in the blood, making it exceptionally effective for respiratory tract infections.

  • Extended Half-Life: Its active metabolite () also has antibacterial activity, allowing for convenient twice-daily (BID) dosing.

Mechanism: Protein Synthesis Inhibition

Clarithromycin works by stopping bacteria from growing, rather than killing them instantly (Bacteriostatic).

Ribosomal Binding: It binds specifically to the 50S subunit of the bacterial ribosome.

Translocation Blockade: This binding prevents the bacteria from moving the growing protein chain, essentially “clogging” their manufacturing machinery.

Growth Arrest: Without the ability to create new proteins, the bacteria cannot replicate, allowing the host’s immune system to finish the job.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai, Clarithromycin is a high-value molecule:

  • Taste Masking Challenge: Clarithromycin is notoriously bitter. For your Oral Suspensions/Dry Syrups, highlighting your micro-encapsulation or taste-masking technology on your marketplace is a major USP for pediatric distributors.

  • Acid Stability: Unlike Erythromycin, Clarithromycin is stable in gastric acid. This ensures high oral bioavailability, a technical detail that B2B buyers looking for quality generics will appreciate.

  • Stability & Packaging: Clarithromycin is moisture-sensitive. At our facility, we utilize Alu-Alu blister packaging to ensure a 36-month shelf life, especially for export to Zone IVb tropical regions like Africa and Southeast Asia.

  • Dossier Support: We provide full CTD/eCTD Dossiers to support your firm in bidding for international hospital tenders and private insurance networks.

Clarithromycin Tablets

Posted on:

What is Clarithromycin 500mg used for?

In the pharmaceutical industry, Clarithromycin 500 mg is a semi-synthetic macrolide antibiotic derived from Erythromycin. As a pharmacist, I view Clarithromycin as a superior choice over older macrolides due to its improved acid stability, better tissue penetration, and its active metabolite (14-hydroxyclarithromycin) which provides synergistic antimicrobial activity.

Primary Clinical Uses

  • Helicobacter pylori Eradication: A critical component of “Triple Therapy” (usually combined with Amoxicillin and a Proton Pump Inhibitor like Omeprazole) to treat peptic ulcers and prevent recurrence.

  • Lower Respiratory Tract Infections: Highly effective for community-acquired pneumonia (CAP), acute exacerbations of chronic bronchitis, and “atypical” pneumonias caused by Legionella or Mycoplasma.

  • Upper Respiratory Tract Infections: Used for acute maxillary sinusitis, tonsillitis, and pharyngitis, especially in patients allergic to Penicillins.

  • Skin and Soft Tissue Infections: Treatment of uncomplicated infections like cellulitis, folliculitis, and erysipelas.

  • MAC Prophylaxis: Used to prevent or treat disseminated Mycobacterium avium complex (MAC) infections in immunocompromised patients (e.g., those with HIV/AIDS).

Mechanism of Action

Clarithromycin is primarily bacteriostatic. It works by penetrating the bacterial cell wall and binding to the 50S ribosomal subunit.

By binding at this specific site, it inhibits translocation, the process where the growing peptide chain moves along the ribosome. This halts bacterial protein synthesis, effectively preventing the bacteria from growing and multiplying, allowing the host’s immune system to clear the infection.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Clarithromycin 500 mg is a high-value antibiotic requiring specialized expertise:

  • Overcoming Bitterness: The Clarithromycin API is notoriously bitter. As a WHO-GMP manufacturer, we utilize advanced film-coating technology or specialized taste-masking polymers to ensure the 500 mg tablet is palatable for patients.

  • Acid Stability: Unlike Erythromycin, Clarithromycin is stable in gastric acid. However, we still optimize our formulation to ensure consistent dissolution and bioavailability, aiming for bioequivalence with the innovator (Biaxin/Klacid).

  • Stability for Global Trade: Clarithromycin is sensitive to moisture. We prioritize Alu-Alu blister packaging to guarantee a 24–36 month shelf life, particularly for export to Zone IVb climates (Africa, Southeast Asia, and the Middle East).

  • B2B & Registration: Our Mumbai-based hub provides comprehensive CTD/eCTD Dossiers and stability data to support our international partners in registering this essential antibiotic.

Clarithromycin Tablets

Add to cart